Bristol-Myers Squibb’s Coast 2 Coast 4 Cancer Ride Raises Over $1 Million for Cancer Research
October 24 2016 - 6:59AM
Business Wire
For third year in a row, BMS employees
participated in a cycling relay to raise funds for Stand Up To
Cancer’s efforts to accelerate cancer research
Bristol-Myers Squibb’s (NYSE:BMY) Coast 2 Coast 4 Cancer
has raised more than $1,050,000 to support Stand Up To Cancer’s
collaborative cancer research programs. In this third year of the
relay, six teams of BMS employees -- with 80 employees in total --
set out on September 7 to bike 2,800 miles in 21 days from the
Oregon Coast to the New Jersey shore to support Stand Up To Cancer,
whose collaborative “Dream Teams” of scientific researchers are
working together to accelerate cancer research and to provide
innovative treatments to patients faster. Bristol-Myers Squibb
matched all money raised by the cyclists, dollar-for-dollar, up to
$500,000.
This Smart News Release features multimedia.
View the full release here:
http://www.businesswire.com/news/home/20161024005137/en/
(Photo: Bristol-Myers Squibb)
“Our teams of cyclists demonstrated what drives all of us at
Bristol-Myers Squibb every day: to challenge ourselves individually
and together to fight cancer. They woke before dawn in towns far
from home to bike along roads stretching across the continent with
one thing in mind: to raise money and awareness to accelerate
cancer research,” said Chris Boerner, PhD, president and head of
U.S. commercial operations, Bristol-Myers Squibb, who rode several
legs of this year’s relay himself. “I’m deeply proud of these
riders, many of whom have never seriously biked before. Coast 2
Coast 4 Cancer is an enormously meaningful event for us all
because we are devoted to fighting for patients.”
One of this year’s riders, Whitney Melton, reflected, “There
were moments on the road that were very hard to push through, to be
honest. We all got tired and we all had to rely on our teammates to
get us over that next hill in 90 degree weather. But every time, we
prevailed and it was because of the inspiring examples of people
facing cancer. We rode for them.”
“The Coast 2 Coast 4 Cancer Ride is so moving because of
the deeply personal commitment these 80 individuals make, one of
whom is a cancer patient,” said Katie Couric, Yahoo Global
News anchor and Stand Up To Cancer co-founder. “Stand Up To
Cancer is about taking collaboration to new levels. Working as
teams, they rode in honor of friends and family who’ve contended
with this terrible disease. The monies pledged in connection with
the ride -- and generously matched by Bristol-Myers Squibb -- will
fund innovative research, enabling more cancer patients to become
long-term survivors. On behalf of all of us at Stand Up, I want to
thank these Bristol-Myers Squibb employees and everyone at the
company for this extraordinary grassroots support of our
efforts.”
About Bristol-Myers
Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose
mission is to discover, develop and deliver innovative medicines
that help patients prevail over serious diseases. For more
information about Bristol-Myers Squibb, visit us at BMS.com or
follow us on LinkedIn, Facebook, Twitter and YouTube.
About Stand Up To Cancer
Stand Up To Cancer® (SU2C) raises funds to accelerate the pace
of research to get new therapies to patients quickly and save lives
now. SU2C, a program of the Entertainment Industry Foundation
(EIF), a 501(c)(3) charitable organization, was established in 2008
by film and media leaders who utilize the industry’s resources to
engage the public in supporting a new, collaborative model of
cancer research, and to increase awareness about progress being
made in the fight against the disease. As SU2C’s scientific
partner, the American Association for Cancer Research (AACR) and a
Scientific Advisory Committee led by Nobel Laureate Phillip A.
Sharp, Ph.D., conduct rigorous, competitive review processes to
identify the best research proposals to recommend for funding,
oversee grants administration, and provide expert review of
research progress.
Current members of the SU2C Council of Founders and Advisors
(CFA) include Katie Couric, Sherry Lansing, Lisa Paulsen, Rusty
Robertson, Sue Schwartz, Pamela Oas Williams, Ellen Ziffren, and
Kathleen Lobb. The late Laura Ziskin was also a co-founder. Sung
Poblete, Ph.D., R.N., has served as SU2C’s president since
2011.
For more information on Stand Up To Cancer, visit
www.standup2cancer.org
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161024005137/en/
Bristol-Myers Squibb:Heather Acker,
973-713-6137heather.acker@bms.comorStand Up To Cancer:Adam Miller,
212-843-8032amiller@rubenstein.com
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Apr 2023 to Apr 2024